Creatinine
Females, Age 50-59
The median serum creatinine for US females aged 50-59 is 0.72 mg/dL (64 µmol/L), with 90% of the population falling between 0.51 mg/dL and 1 mg/dL.
NHANES 2017-March 2020 Pre-Pandemic 2017-2020 · Sample size: 733 participants · Unit: mg/dL
Percentile Distribution
Unit:
| Percentile | P5 | P10 | P25 | P50 | P75 | P90 | P95 |
|---|---|---|---|---|---|---|---|
| Value (mg/dL) | 0.51 | 0.57 | 0.64 | 0.72 | 0.81 | 0.93 | 1.00 |
| 95% CI | 0.48 | 0.54 | 0.62 | 0.70 | 0.80 | 0.88 | 0.97 |
| Percentile | Value (mg/dL) | 95% CI |
|---|---|---|
| P5 | 0.51 | 0.48 |
| P10 | 0.57 | 0.54 |
| P25 | 0.64 | 0.62 |
| P50 | 0.72 | 0.70 |
| P75 | 0.81 | 0.80 |
| P90 | 0.93 | 0.88 |
| P95 | 1.00 | 0.97 |
The 95% confidence interval (CI) is the range of values for the population percentile that are consistent with this sample, given how NHANES selected participants. It describes uncertainty in the percentile, not in any one person's result.
0.64 0.72 0.81
P25 P50 P75
P5 0.51 P95 1.00
Data and Methodology
- Dataset
- NHANES 2017-March 2020 Pre-Pandemic ( NHANES 2017-2020 2020 , Survey-weighted percentiles from full MEC sample)
- Survey years
- 2017-2020
- Measurement
- Measured by enzymatic assay (creatininase) on Roche Cobas 6000 (c501 module). How it was measured
- Sample size
- 733 participants
- Reference population
- US civilian non-institutionalized females aged 50-59 from NHANES 2017-March 2020. Includes the full population (not restricted to healthy individuals) to reflect the population distribution.
- Exclusion criteria
-
- Missing serum creatinine measurement (LBXSCR)
- Missing or zero MEC sample weight (WTMEC)
- Age outside 50-59 range
- Notes
- Percentiles computed using the combined pre-pandemic MEC weight (WTMECPRP). Creatinine measured as LBXSCR in mg/dL from refrigerated serum.